Status: Not yet recruiting
Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections
This is a randomized, double-masked study to evaluate the tolerability and safety of IRX-101 versus 5% povidone-iodine (PI) in subjects receiving intravitreal anti-VEGF injections.
Participants needed: 240
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: iRenix Medical, Inc.Updated: Apr 3, 2026Locations: 1
Eligibility criteria
Capable of giving informed consent [+2]
Current or past diagnosis of endophthalmitis [+6]